William Blair Upgrades Infinity Pharmaceutical (INFI) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Infinity Pharmaceuticals, Inc. (INFI) Tops Q1 EPS by 6c
August 5, 2014 8:14 AM EDTInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.78), $0.06 better than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.
... More


